naltrexone has been researched along with Fatty Liver in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brach, BS; Luderer, M; Meulien, D; Mueller, S; Schou, MB; Zhang, D | 1 |
| Ahmadian, S; Dehpour, AR; Ebrahim-Habibi, A; Kashani-Amin, E; Malek, MR; Shafizadeh, M | 1 |
| Dehpou, AR; Dehpour, AR; Hassanzadeh, G; Moslehi, A; Nabavizadeh, F; Nahrevanian, H; Sohanaki, H; Tavanga, SM; Zekri, A | 1 |
| Mehal, WZ; Shaker, ME; Trawick, BN | 1 |
| Amiri, F; Moslehi, A; Nabavizadeh, F; Zekri, A | 1 |
1 trial(s) available for naltrexone and Fatty Liver
| Article | Year |
|---|---|
Open-label Study with Nalmefene as Needed Use in Alcohol-Dependent Patients with Evidence of Elevated Liver Stiffness and/or Hepatic Steatosis.
Topics: Alcohol Drinking; Alcoholism; Elasticity; Elasticity Imaging Techniques; Fatty Liver; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Treatment Outcome | 2020 |
4 other study(ies) available for naltrexone and Fatty Liver
| Article | Year |
|---|---|
Investigating the role of endogenous opioid system in chloroquine-induced phospholipidosis in rat liver by morphological, biochemical and molecular modelling studies.
Topics: Animals; Chemical and Drug Induced Liver Injury; Chloroquine; Disease Models, Animal; Fatty Liver; Glycine; Hippurates; Liver; Male; Molecular Docking Simulation; Molecular Dynamics Simulation; Naltrexone; Narcotic Antagonists; Opioid Peptides; Phospholipids; Rats; Receptors, Opioid, mu; Signal Transduction | 2020 |
Naltrexone attenuates endoplasmic reticulum stress induced hepatic injury in mice.
Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents; Aspartate Aminotransferases; bcl-2-Associated X Protein; Biomarkers; Caspase 3; Chemical and Drug Induced Liver Injury; Cholesterol; Cytoprotection; Disease Models, Animal; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Fatty Liver; Liver; Liver Circulation; Male; Mice; Mice, Inbred C57BL; Naltrexone; Narcotic Antagonists; Non-alcoholic Fatty Liver Disease; Proto-Oncogene Proteins c-bcl-2; Triglycerides; Tumor Necrosis Factor-alpha; Tunicamycin | 2014 |
The novel TLR9 antagonist COV08-0064 protects from ischemia/reperfusion injury in non-steatotic and steatotic mice livers.
Topics: Animals; Dendritic Cells; Diet, High-Fat; Fatty Liver; Liver; Liver Function Tests; Macrophages, Peritoneal; Male; Mice, Inbred C57BL; Naltrexone; Reperfusion Injury; Toll-Like Receptor 9 | 2016 |
Naltrexone changes the expression of lipid metabolism-related proteins in the endoplasmic reticulum stress induced hepatic steatosis in mice.
Topics: Activating Transcription Factor 6; Animals; eIF-2 Kinase; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Endoribonucleases; Fatty Liver; Gene Expression; Lipid Metabolism; Mice, Inbred C57BL; Naltrexone; Protein Serine-Threonine Kinases; Sterol Regulatory Element Binding Protein 1; Transcription Factors; Tunicamycin | 2017 |